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Although the presence of myomas is almost never
associated with mortality, myomas may cause morbid-
ity and affect the quality of life [1]. However, a recent
publication by Su and colleagues on the topic of inter-
nal bleeding from a ruptured serosa vein covering the
myoma surface mimicking upper gastrointestinal bleed-
ing calls attention to the alarming possibility of this
unusual clinical presentation of the uterine myomas,
which might result in a life-threatening status [2]. In fact,
there are many reports on unusual clinical presenta-
tion of uterine myomas [3–6]. Herein, we review the
symptomatology of uterine myomas.
Most women with myomas are asymptomatic; there-
fore, an observation is expected and follow-up is often
recommended. Only the following conditions call for
definite treatment: severe menstrual symptoms, pelvic
pain, pressure complaints, subfertility, and pregnancy-
related complications [7–9].
Disturbance of menstruation is the most frequent
presenting symptom in women with myomas and the
leading reason for therapy [10]. The exact proportion
of abnormal bleeding related to myomas is difficult to
determine because of the difficulty in assessing myoma
prevalence and the differing criteria for abnormal uterine
bleeding. A randomized study involving a sample of 878
non-care-seeking urban women found that the pre-
valence of myoma was 65% [10]. Forty-six percent of 
the women with myomas had an increased risk of self-
reported “gushing-type” bleeding. However, another
population-based cohort study with a myoma prevalence
rate of 21.4% found no statistically significant relation-
ship between the presence of myomas and menstrual
cycle characteristics [11].
There is no abnormal bleeding pattern specific to
myomas. Women with myomas may develop menorrha-
gia or metrorrhagia, or both. The probable mechanism
of myoma-related bleeding had been attributed to the
expanded surface area of the endometrium or local com-
pression of veins in the interior uterine layers [12]. Results
from several recent studies weighed against these hypo-
theses but suggested the role of growth factor dysfunc-
tion [13]. The dysregulation of growth factor may be
responsible for the observation of increasing venules and
arterioles and venule ectasia in the myomatous uteri [13].
Gynecologic pain, such as dysmenorrhea, dyspare-
unia or non-cyclic pelvic pain, has been described as an
associated symptom of myomas. A population-based,
non-care-seeking cohort of women aged 20 to 50 years
was evaluated by self-reported gynecologic pain on a
visual analog scale and by ultrasound to determine the
presence, size, volume and location of myomas [14].
Of the 635 women screened, myomas were detected 
in 96 (15%). The presence of myoma was related to
dyspareunia (odds ratio [OR], 2.8; confidence interval
[CI], 0.9–8.3) and non-cyclic pelvic pain (OR, 2.6; CI,
0.9–7.6), rather than dysmenorrhea (OR, 1.1; CI, 0.5–
2.6) [13]. Neither the number nor the total volume of
myomas was related to pain.
Myomas may be associated with pressure effects,
leading to urinary symptoms. Studies assessing the treat-
ment effect on myomas found that urinary frequency
and urgency improved after reduction of uterine volume
[15]. These results support the notion that increased
uterine volume caused by myomas may lead to urinary
symptoms.
This summary of the symptomatology of uterine
myomas shows that, although they are still not well
understood, much has been learned about them.
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